{
 "name": "松瑞藥",
 "slug": "tw-4167",
 "aliases": [
  "松瑞製藥股份有限公司",
  "SLC",
  "4167"
 ],
 "ticker": "4167",
 "industry": "生技醫療業",
 "website": "https://www.saviorlifetec.com.tw/",
 "summary": "松瑞藥（4167）是上櫃的生技醫療類股公司，2004 年成立，2015 年上櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "松瑞製藥股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "英文簡稱",
   "value": "SLC",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心上櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "上櫃日期",
   "value": "2015-09-08",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "成立日期",
   "value": "2004-01-30",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "董事長",
   "value": "漢友財務管理顧問股份有限公司代表人李香雲",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "總經理",
   "value": "陳志芳",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "實收資本額",
   "value": 3315543070,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "勤業眾信聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "公司網址",
   "value": "https://www.saviorlifetec.com.tw/",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_O"
  },
  {
   "claim": "月營收（2026-09）",
   "value": 104089,
   "unit": "新台幣千元",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔數值、單位與as_of保留；2026-10-22重開官方OpenAPI逐值核對，資料年月11509、出表日期1151017，欄位：營業收入-當月營收；僅更正不符白名單的舊二手來源網址。"
  },
  {
   "claim": "月營收年增率（2026-09）",
   "value": 33.74,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔數值、單位與as_of保留；2026-10-22重開官方OpenAPI逐值核對，資料年月11509、出表日期1151017，欄位：營業收入-去年同月增減(%)；僅更正不符白名單的舊二手來源網址。"
  },
  {
   "claim": "累計營收年增率（2026 年 1 月至 09 月）",
   "value": -4.94,
   "unit": "%",
   "as_of": "2026-10-17",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap05_O",
   "note": "原檔數值、單位與as_of保留；2026-10-22重開官方OpenAPI逐值核對，資料年月11509、出表日期1151017，欄位：累計營業收入-前期比較增減(%)；僅更正不符白名單的舊二手來源網址。"
  },
  {
   "claim": "管線：Meropenem（美洛培南）",
   "value": "重症細菌感染｜原料藥及針劑已商業化，針劑取得美國及歐洲銷售許可｜美國、葡萄牙、德國",
   "unit": "",
   "as_of": "2026-05-06",
   "source": "https://www.saviorlifetec.com.tw/uploads/annual-reports/1787190867162-cy9a3c.pdf",
   "note": "2025年報於2026-05-06刊印；適應症僅按年報廣效抗生素／重症感染描述，不作個別地區仿單延伸。"
  },
  {
   "claim": "管線：Ertapenem sodium for injection（厄他培南鈉針劑）",
   "value": "複雜性腹腔內感染、社區型肺炎、急性骨盆腔感染、複雜性尿道及皮膚軟組織感染｜已獲NMPA上市藥證｜中國大陸",
   "unit": "",
   "as_of": "2025-04-08",
   "source": "https://mops.twse.com.tw/mops/#/web/t05st01?companyId=4167",
   "note": "發言日期 2025-04-08 15:44:39；主旨 公告本公司厄他培南針劑產品獲得中國核准上市並取得藥證；序號 1；enterDate=1140408。 為公司首張中國市場藥證；核准與開始銷售區分，不把上市準備寫成已產生收入。"
  },
  {
   "claim": "管線：SLC-037",
   "value": "適應症未揭露｜實驗室製程評估與專利布局突破中｜地區未揭露",
   "unit": "",
   "as_of": "2026-05-06",
   "source": "https://www.saviorlifetec.com.tw/uploads/annual-reports/1787190867162-cy9a3c.pdf",
   "note": "2025年報第65頁（印刷61頁）列SLC-037製程評估及專利布局，未揭露學名、適應症細項或臨床試驗期別；不從公司整體抗生素業務推定適應症。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-4167.json",
 "generated_at": "2026-10-23T01:06:05.573Z"
}